Invention Grant
- Patent Title: Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
-
Application No.: US14976998Application Date: 2015-12-21
-
Publication No.: US09763952B2Publication Date: 2017-09-19
- Inventor: Giorgio Caravatti , Sylvie Chamoin , Pascal Furet , Klemens Hogenauer , Konstanze Hurth , Karen Kammertoens , Ian Lewis , Henrik Moebitz , Alexander Baxter Smith , Nicolas Soldermann , Romain Wolf , Frederic Zecri
- Applicant: Giorgio Caravatti , Sylvie Chamoin , Pascal Furet , Klemens Hogenauer , Konstanze Hurth , Karen Kammertoens , Ian Lewis , Henrik Moebitz , Alexander Baxter Smith , Nicolas Soldermann , Romain Wolf , Frederic Zecri
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Laura K. Madden
- Main IPC: A61K31/538
- IPC: A61K31/538 ; A61K31/5383 ; C07D498/04 ; C07D413/14 ; C12Q1/25 ; C12N9/12
Abstract:
The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, V, W, U, Q, R1, R5, R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
Public/Granted literature
- US20160106753A1 Dihydro-Benzo-Oxazine and Dihydro-Pyrido-Oxazine Derivatives Public/Granted day:2016-04-21
Information query
IPC分类:
